DUSA Pharmaceuticals is an integrated dermatology pharmaceutical company chiefly engaged in the development and marketing of its Levulan PDT technology platform. The company’s Levulan Kerastick (aminolevulinic acid HCI) for Topical Solution, 20% plus blue light illumination using DUSA’s BLU-U Blue Light Photodynamic Therapy Illuminator is currently approved for treating minimally to moderately thick actinic keratoses (AKs) of the face of scalp. For more information, visit the company’s Web site at www.dusapharma.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: